Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest fibrosis Stories

2013-12-10 08:30:34

- Largest multi-center registry in world to advance understanding of pulmonary fibrosis - BRISBANE, Calif., Dec. 10, 2013 /PRNewswire/ -- InterMune (NASDAQ: ITMN) today announced its support of the Pulmonary Fibrosis Foundation, a leading patient advocacy organization dedicated to advancing care for people with pulmonary fibrosis worldwide, to establish the Pulmonary Fibrosis Foundation Care Center Network and Patient Registry. The Care Center Network will launch in 2014 with nine...

2013-11-25 08:27:20

-- Announces $20 Million Series A Financing -- REDWOOD CITY, Calif., Nov. 25, 2013 /PRNewswire/ -- ARMO BioSciences, Inc., a clinical-stage biotechnology company, today announced that it initiated the first cohort of patients with advanced solid tumors in a Phase 1 clinical trial of AM0010, a PEGylated form of recombinant human interleukin-10 (IL-10). Based on extensive clinical and preclinical data, ARMO plans to develop this unique molecule for known indications and innovative...

2013-11-11 10:28:31

Nature Medicine paper pinpoints where, how to intervene A team of scientists that includes Saint Louis University researchers has identified a new way to intervene in the molecular and cellular cascade that causes fibrosis – a condition where the body's natural process of forming scars for wound healing goes into overdrive and causes diseases. The findings, published Nov. 10 in the advance online issue of Nature Medicine, demonstrate a potential novel therapeutic approach to treat...

2013-11-08 16:25:25

Breathe Benefit 2013: Community Inspiring a Cure Honors Co-Founder and Acknowledges Research Grant Recipients and Volunteer Leaders CHICAGO, Nov. 8, 2013 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) held its annual dinner, the Breathe Benefit 2013: Community Inspiring a Cure, on October 26, 2013, at The Drake Hotel in Chicago. The event raised almost $200,000 to support the Foundation's mission to find a cure for idiopathic pulmonary fibrosis (IPF), advocate...

2013-10-30 10:56:50

Severity of fibrosis similar in men and post-menopausal women New research suggests that estrogen protects women with nonalcoholic steatohepatitis (NASH) from severe liver fibrosis. According to the study published online in Hepatology, a journal of the American Association for the Study of Liver Diseases, men are at higher risk of more severe fibrosis compared to women prior to menopause, but liver fibrosis severity is similar in men and post-menopausal women. Non-alcoholic fatty liver...

2013-10-09 16:23:35

SAN FRANCISCO, Oct. 9, 2013 /PRNewswire-USNewswire/ -- The Scleroderma Research Foundation today said that researchers at The Johns Hopkins University working in a novel mouse model of Stiff Skin Syndrome have made key discoveries that may have broad implications for future scleroderma therapy. In a report to be published online on October 10th in Nature, scientists show that integrin-modulating agents can arrest fibrosis in a model of scleroderma-like skin fibrosis and, more...

2013-10-09 12:26:15

Conference brings together Daughters from across the United States to build awareness of devastating disease CULVER CITY, Calif., Oct. 9, 2013 /PRNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) is pleased to announce the first ever Daughters of Pulmonary Fibrosis Leadership Conference to be held at the Marriott Marquis in downtown Atlanta, Friday, October 11 to Saturday, October 12. This unique program will bring together relatives of past and present patients with idiopathic...

2013-09-20 11:26:58

A new, non-invasive imaging technique, magnetic resonance elastography (MRE), can now help physicians accurately detect fibrosis (scarring) in children with chronic liver disease – a growing problem due in part to increasing obesity rates. A new study shows that MRE detects such chronic diseases as non-alcoholic fatty liver disease (NAFLD), which is increasingly common in children and teens, affecting an estimated 13 percent of adolescents. NAFLD can lead to progressive liver disease and...

2013-08-16 16:22:19

Foundation and Community Initiatives Offer Opportunities for Improving Patient Advocacy, Education, and Awareness in September CHICAGO, Aug. 16, 2013 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced today that it has designated September 7 as the second annual Global Pulmonary Fibrosis Awareness Day, as part of a month of awareness activities. Awareness is critical for any disease, but it is even more important for a rare disease like pulmonary fibrosis (PF). As...

2013-07-24 08:30:29

NORCROSS, Ga., July 24, 2013 /PRNewswire-USNewswire/ -- Galectin Therapeutics (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced today that the first patient has been successfully dosed in a Phase 1 clinical trial of GR-MD-02. The first-in-man study will evaluate the safety, tolerability, and exploratory biomarkers for efficacy for single and multiple doses of GR-MD-02 when administered to patients with fatty...